JD Health International Inc. (06618.HK) Latest Company News

Sep 3, 2026, 12:07 UTC
On September 3, 2026, Jiuzhoutong Pharmaceutical Group signed a strategic cooperation agreement with JD Health to deepen collaboration in supply chain, fulfillment, consumer scenarios, and digital procurement.
Source:
- finance.sina.cn
Aug 25, 2026, 11:29 UTC
JD Health held a merchant recruitment conference in Zhengzhou, Henan, on August 25, 2026, announcing cooperation policies and operational benefits for local health industry merchants, including up to 0 commission for new merchants.
Source:
- finance.sina.cn
Aug 13, 2026, 08:31 UTC
JD Health reported a net profit of 3.44 billion yuan for the first half of 2026, with a gross margin of 26.1%, slightly above the estimated 25.9%.
Source:
Aug 13, 2026, 03:44 UTC
JD Health announced a deep cooperation agreement with dermatology pharmaceutical company LEO Pharma covering new drug launches, AI and digital marketing innovation, chronic disease patient management, supply chain collaboration, and long-term brand building, aiming to create a dedicated skin health service brand on the JD Health platform over the next ten years.
Source:
- aastocks.com
Jul 18, 2026, 03:27 UTC
JD Health showcased its AI doctor 'Dawei' and evidence-based medicine AI product 'JD Zhiyi' at the 2026 World Artificial Intelligence Conference (WAIC) in Shanghai.
Source:
Jul 17, 2026, 03:33 UTC
JD Health and Lunan Pharmaceutical Group signed a strategic cooperation agreement on July 16, 2026, to collaborate on digital platforms, omnichannel marketing, pharmaceutical supply chain, new product R&D, and AI empowerment.
Source:
- finance.sina.cn
- aastocks.com
Jul 15, 2026, 01:14 UTC
JD Health and Everest Medicines signed a strategic cooperation agreement to jointly explore new models for full-cycle services of innovative drugs.
Source:
- finance.sina.cn
Jul 8, 2026, 03:20 UTC
China's Ministry of Commerce directed pharmaceutical distribution companies in Guangxi to ensure medical supplies during flood relief.
Source:
- finance.sina.cn
Jul 7, 2026, 08:20 UTC
JD Health announced that its pharmaceutical services now cover one million villages across China and launched the 'Bai Cun Yun Yao Xiang' public welfare program.
Source:
- finance.sina.cn
Jul 4, 2026, 11:52 UTC
Hong Kong-listed companies, led by Tencent Holdings, AIA Group, and Xiaomi Corporation, have conducted share buybacks totaling over 900 billion Hong Kong dollars year-to-date, with June 2026 reaching a monthly record of over 300 billion Hong Kong dollars.
Source:
- wap.eastmoney.com
- finance.sina.cn

06618.HK

On September 3, 2026, Jiuzhoutong Pharmaceutical Group signed a strategic cooperation agreement with JD Health to deepen collaboration in supply chain, fulfillment, consumer scenarios, and digital procurement.

JD Health held a merchant recruitment conference in Zhengzhou, Henan, on August 25, 2026, announcing cooperation policies and operational benefits for local health industry merchants, including up to 0 commission for new merchants.

JD Health reported a net profit of 3.44 billion yuan for the first half of 2026, with a gross margin of 26.1%, slightly above the estimated 25.9%.

JD Health showcased its AI doctor 'Dawei' and evidence-based medicine AI product 'JD Zhiyi' at the 2026 World Artificial Intelligence Conference (WAIC) in Shanghai.

JD Health and Lunan Pharmaceutical Group signed a strategic cooperation agreement on July 16, 2026, to collaborate on digital platforms, omnichannel marketing, pharmaceutical supply chain, new product R&D, and AI empowerment.

JD Health and Everest Medicines signed a strategic cooperation agreement to jointly explore new models for full-cycle services of innovative drugs.

China's Ministry of Commerce directed pharmaceutical distribution companies in Guangxi to ensure medical supplies during flood relief.

JD Health announced that its pharmaceutical services now cover one million villages across China and launched the 'Bai Cun Yun Yao Xiang' public welfare program.

Hong Kong-listed companies, led by Tencent Holdings, AIA Group, and Xiaomi Corporation, have conducted share buybacks totaling over 900 billion Hong Kong dollars year-to-date, with June 2026 reaching a monthly record of over 300 billion Hong Kong dollars.